Rat Smyd1 ORF/cDNA clone-Adeno-associate virus(AAV) plasmid (NM_001106595)

Cat. No.: pGMAAV001971
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days

Pre-made Rat Smyd1/ Adeno-associated virus expression plasmid (ITR-vector) for Smyd1 AAV packaging, Smyd1 AAV production.The purified Rat Smyd1/ AAV particle serves as an invaluable asset for in-depth in vivo Smyd1 studies, mechanism of action (MOA) research, and the evolution of Smyd1-associated gene therapy strategies.

Our GM-AAV ITR vector is optimized with the G-NEXT™ multi-serotypes AAV vector system. Explore the G-NEXT™ system in detail.


Purchase
Shipping fee: Limited-time free
For payment issues, contact us.


Product Description

Catalog ID pGMAAV001971
Gene Name Smyd1
Accession Number NM_001106595
Gene ID 297333
Species Rat
Product Type Adeno-associate virus(AAV) plasmid (overexpression)
Insert Length 1473 bp
Gene Alias
Fluorescent Reporter EGFP
Mammalian Cell Selection Null
Fusion Tag 3xflag (C-Terminal)
Promoter CTNT
Resistance Amplicin
ORF Nucleotide Sequence ATGACAGTAGGCAGCATGGAGAATGTGGAGGTCTTTACTTCCGAGGGCAAAGGCAGAGGACTGAAGGCCACGAAGGAGTTCTGGGCTGCGGATGTCATCTTTGCTGAGAGGGCTTATTCGGCAGTGGTTTTTGACAGCCTCATTAACTTCGTGTGCCACACCTGCTTCAAGAGGCAGGAGAGGCTCCATCGCTGCGGGCAATGCAAGTTCGCCCATTACTGCGACCGCACATGCCAGAAGGATGCCTGGCTGAACCACAAGAACGAGTGCTCTGCCATCAAGAGATACGGGAAGGTGCCCAACGAAAATATCAGGCTGGCAGCCCGCATCATGTGGCGGGTGGAGAGAGAGGGCACTGGACTCACAGAGGGCTGCCTGGTGTCAGTGGATGACTTACAGAACCATGTGGAGCACTTTGGGGAGGAGGAGCAGAAGGAACTACGAGTAGACGTGGATACATTCTTGCAGTACTGGCCACCACAGAGCCAGCAGTTCAGCATGCAGTACATCTCACACATCTTTGGCGTGATCAACTGCAATGGTTTCACACTCAGTGACCAGAGAGGGCTACAGGCAGTGGGCGTGGGCATCTTCCCCAACCTGGGCCTGGTGAACCATGACTGCTGGCCAAACTGCACTGTCATATTCAACAATGGCAATCATGAGGCGGTGAAATCCATGTTTCACACGCAGATGAGGATTGAGCTCCGGGCCCTGGGCAAGATCTCAGAAGGTGAGGAGCTGACGGTGTCCTACATAGACTTCCTCCACCTCAGCGAGGAGCGCAGGCAGCAGCTGAAGAAGCAGTACTACTTTGACTGCTCCTGTGAACACTGCCAGAAGGGGCTGAAGGACGACCTCTTCCTGGCAGTGAAGGAAGACCCCAAGCCCTCCCAGGAGGTGGTGAAGGAGATGACACAATTCTCAAAGGATACACTGGAAAAAATAGACAAGGCTCGCTCTGAGGGTTTGTATCACGAGGTTGTGAAGCTGTGTCGGGAGTGCCTGGAGAAGCAGGAACCAGTGTTTGCTGACACCAACCTCTACGTGCTTCGGTTGCTAAGCATTGTGTCAGAAGTCCTCTCCTACCTCCAGGCCTTTGAAGAGGCCTCCCATTATGCCAGGAGGATGGTGGATGGCTACATGAAACTCTACCACCATAACAATGCCCAACTGGGCATGGCTGTGATGCGGGCAGGGCTGACCAACTGGCATGCTGGTCACATTGAAGTAGGGCACGGGATGATCTGCAAAGCCTATGCTATTCTCCTGGTGACCCATGGACCCTCCCACCCTATCACCAAAGACTTAGAGGCCATGCGGATGCAGACAGAGATGGAGCTGCGTATGTTCCGCCAAAATGAATTCATGTACCACAAAATGCGAGAGGCTGCCCTGAACAACCAGCCCATGCAGGTCATGGCTGAGCCCAGCAACGAGCCAGCCCCAGCTCTGTTCCATAAGAAGCAATGA
ORF Protein Sequence MTVGSMENVEVFTSEGKGRGLKATKEFWAADVIFAERAYSAVVFDSLINFVCHTCFKRQERLHRCGQCKFAHYCDRTCQKDAWLNHKNECSAIKRYGKVPNENIRLAARIMWRVEREGTGLTEGCLVSVDDLQNHVEHFGEEEQKELRVDVDTFLQYWPPQSQQFSMQYISHIFGVINCNGFTLSDQRGLQAVGVGIFPNLGLVNHDCWPNCTVIFNNGNHEAVKSMFHTQMRIELRALGKISEGEELTVSYIDFLHLSEERRQQLKKQYYFDCSCEHCQKGLKDDLFLAVKEDPKPSQEVVKEMTQFSKDTLEKIDKARSEGLYHEVVKLCRECLEKQEPVFADTNLYVLRLLSIVSEVLSYLQAFEEASHYARRMVDGYMKLYHHNNAQLGMAVMRAGLTNWHAGHIEVGHGMICKAYAILLVTHGPSHPITKDLEAMRMQTEMELRMFRQNEFMYHKMREAALNNQPMQVMAEPSNEPAPALFHKKQ

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    Category Cat No. Products Name
    ORF Viral Vector vGMAAV001971 Rat Smyd1 Adeno-associate virus(AAV) particle




    About GMVC

    GDU

    GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.